Last reviewed · How we verify
COVID-19 Vaccine 2
At a glance
| Generic name | COVID-19 Vaccine 2 |
|---|---|
| Sponsor | ModernaTX, Inc. |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- COVID-19 Vaccine 2 CI brief — competitive landscape report
- COVID-19 Vaccine 2 updates RSS · CI watch RSS
- ModernaTX, Inc. portfolio CI